ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,196Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 537

$2.24M Total Retail Price of All Prescriptions

Rank: 1 out of 537

921 Patients Receiving at Least One Drug in Part D
29%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

19% of this provider’s 921 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 9,344 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$72 was the average price of a prescription from this provider, compared to $126 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SULFAMETHOXAZOLE-TRIMETHOPRIM 3,226 878 10 1 22
PREDNISONE 1,933 455 10 2 21
AMLODIPINE BESYLATE 1,053 281 3 1
ATORVASTATIN CALCIUM 951 356 4 26
CARVEDILOL 940 230 5 7
CLONIDINE HCL 825 189 10 6 10
OMEPRAZOLE 798 225 7 19
FUROSEMIDE 795 316 8 2
FAMOTIDINE 744 138 9 30
METOPROLOL TARTRATE 735 277 10 9
DIOVAN 643 264 11 24
LEVOTHYROXINE SODIUM 545 155 12 18
PRAVASTATIN SODIUM 536 204 13 28
NIFEDIPINE ER 530 132 14 16
NEXIUM 526 97 15 23
HYDROCODONE-ACETAMINOPHEN 492 144 S3 16 8
LANTUS 468 185 17 44
ENALAPRIL MALEATE 442 145 18 39
CRESTOR 427 168 19 49
ATENOLOL 426 106 20 51
ALENDRONATE SODIUM 405 129 21 55
INSULIN SYRINGE 381 156 22 47
TAMSULOSIN HCL 379 135 23 43
METOPROLOL SUCCINATE 375 106 24 20
LISINOPRIL 370 155 25 3
PANTOPRAZOLE SODIUM 365 76 26 33
ALLOPURINOL 360 155 27 14
HYDRALAZINE HCL 303 104 28 11
ZOLPIDEM TARTRATE 298 58 29 27
CALCITRIOL 295 66 30 13
GABAPENTIN 288 89 31 25
LIPITOR 278 98 32 82
NIFEDIAC CC 277 52 10 33 63
LOSARTAN POTASSIUM 274 82 34 15
POTASSIUM CHLORIDE 242 142 35 29
WARFARIN SODIUM 228 91 36 41
METHYLDOPA 199 62 R 10 37 102
LANTUS SOLOSTAR 190 50 38 122
GLIPIZIDE ER 185 51 39 74
PEN NEEDLE 172 35 40 77
HUMALOG 168 29 41 128
SENSIPAR 164 53 42 5
METOCLOPRAMIDE HCL 161 29 43 62
MINOXIDIL 158 36 44 34
SERTRALINE HCL 155 49 45 53
CLOPIDOGREL 145 40 46 52
NOVOLOG FLEXPEN 136 48 47 100
LOVAZA 135 61 48 99
TRAMADOL HCL 134 34 49 31
LEVEMIR FLEXPEN 126 59 50 125
CITALOPRAM HBR 125 19 51 68
LABETALOL HCL 122 28 52 36
GLIPIZIDE 121 53 53 42
PLAVIX 118 45 54 64
NOVOLOG 113 52 55 106
DIPYRIDAMOLE 113 0 R 55 126
DOXAZOSIN MESYLATE 109 40 57 37
ISOSORBIDE MONONITRATE ER 105 28 58 54
CIPROFLOXACIN HCL 101 33 59 59
PROGRAF 100 58 60 158
VERAPAMIL ER 99 11 61 66
HUMULIN R 97 48 62 132
BYSTOLIC 94 19 63 78
ESCITALOPRAM OXALATE 93 27 64 97
LEVEMIR 91 27 65 162
CYMBALTA 90 34 66 108
NITROFURANTOIN MONO-MACRO 89 34 67 116
NOVOLIN R 89 29 67 104
PROMETHAZINE HCL 86 0 R 69 88
VALCYTE 82 0 70 71
ZETIA 82 38 70 134
LOVASTATIN 81 17 72 101
DEXILANT 80 15 73 167
MYFORTIC 79 36 74 168
NIFEDICAL XL 75 0 75 56
AZATHIOPRINE 75 21 75 173
COLCRYS 69 25 77 123
HUMULIN 70-30 69 45 77 181
CYCLOBENZAPRINE HCL 68 0 R 79 132
BUMETANIDE 64 25 80 48
LYRICA 63 0 81 96
RAMIPRIL 62 24 82 83
LEVOFLOXACIN 62 22 82 60
ACYCLOVIR 59 12 84 129
PHOSPHA 250 NEUTRAL 58 36 10 85 190
LEFLUNOMIDE 57 23 86 108
CLOTRIMAZOLE 57 16 86 84
VENLAFAXINE HCL ER 56 0 88 195
WELCHOL 55 23 89 199
FLUCONAZOLE 54 0 90 202
ACTONEL 53 15 91 205
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 1, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.